Federal Register Notice: FDA’s Anesthetic and Analgesic Drug Products Advisory Committee will meet 3/18, from 8 a.m. to 5 p.m. at the Holiday Inn Gaithersburg, Grand Ballroom, 2 Montgomery Village Ave., Gaithersburg, MD. The committee will discuss an Organon USA Inc. NDA for sugammadex sodium injection for the proposed indication of reversal of moderate or deep neuromuscular blockade induced by rocuronium or vecuronium. Contact Stephanie L. Begansky, (301) 796-9001. To view this notice, click here.